DBCO-PEG4-VA-PBD is an antibody-conjugated active molecule used in targeted cancer therapy; it serves as a click chemistry reagent for strain-promoted alkyne-azide cycloaddition (SPAAC) reactions due to its DBCO group, enabling conjugation with azide-containing molecules.